DK175853B1 - Sekretoriske ledersekvenser - Google Patents
Sekretoriske ledersekvenser Download PDFInfo
- Publication number
- DK175853B1 DK175853B1 DK199000729A DK72990A DK175853B1 DK 175853 B1 DK175853 B1 DK 175853B1 DK 199000729 A DK199000729 A DK 199000729A DK 72990 A DK72990 A DK 72990A DK 175853 B1 DK175853 B1 DK 175853B1
- Authority
- DK
- Denmark
- Prior art keywords
- leu
- ser
- phe
- ile
- lys
- Prior art date
Links
- UYDYIIZGDLDBCF-GVHYBUMESA-N C[C@H](CC1)CC1C=C Chemical compound C[C@H](CC1)CC1C=C UYDYIIZGDLDBCF-GVHYBUMESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888817598A GB8817598D0 (en) | 1988-07-23 | 1988-07-23 | Dna & peptide sequences |
GB898906920A GB8906920D0 (en) | 1989-03-28 | 1989-03-28 | Peptide and dna sequences |
PCT/GB1989/000816 WO1990001063A1 (en) | 1988-07-23 | 1989-07-14 | New secretory leader sequences |
Publications (3)
Publication Number | Publication Date |
---|---|
DK72990A DK72990A (da) | 1990-03-21 |
DK72990D0 DK72990D0 (da) | 1990-03-21 |
DK175853B1 true DK175853B1 (da) | 2005-04-04 |
Family
ID=26294196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199000729A DK175853B1 (da) | 1988-07-23 | 1990-03-21 | Sekretoriske ledersekvenser |
Country Status (15)
Country | Link |
---|---|
US (1) | US5302697A (da) |
EP (1) | EP0387319B1 (da) |
JP (1) | JP3092811B2 (da) |
KR (1) | KR100195632B1 (da) |
AT (1) | ATE135045T1 (da) |
AU (1) | AU633020B2 (da) |
CA (1) | CA1340547C (da) |
DE (1) | DE68925893T2 (da) |
DK (1) | DK175853B1 (da) |
FI (1) | FI104564B (da) |
GB (1) | GB2230268B (da) |
HU (1) | HU213571B (da) |
IE (1) | IE62266B1 (da) |
IL (1) | IL91024A (da) |
WO (1) | WO1990001063A1 (da) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340772C (en) * | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
US5759802A (en) * | 1988-10-26 | 1998-06-02 | Tonen Corporation | Production of human serum alubumin A |
DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
US5766883A (en) * | 1989-04-29 | 1998-06-16 | Delta Biotechnology Limited | Polypeptides |
FR2650598B1 (fr) * | 1989-08-03 | 1994-06-03 | Rhone Poulenc Sante | Derives de l'albumine a fonction therapeutique |
DK300090D0 (da) * | 1990-12-19 | 1990-12-19 | Novo Nordisk As | Fremgangsmaade til fremstilling af leadersekvenser |
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5521086A (en) * | 1993-09-16 | 1996-05-28 | Cephalon, Inc. | Secretion sequence for the production of a heterologous protein in yeast |
US5919654A (en) * | 1995-02-03 | 1999-07-06 | Asahi Glass Company Ltd. | Secretion signal gene and expression vector containing it |
US5712114A (en) * | 1995-06-06 | 1998-01-27 | Basf Aktiengesellschaft | Compositions for expression of proteins in host cells using a preprocollagen signal sequence |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
GB9712370D0 (en) | 1997-06-14 | 1997-08-13 | Aepact Ltd | Therapeutic systems |
ES2178854T3 (es) * | 1997-11-07 | 2003-01-01 | Conjuchem Inc | Bibliotecas de marcadores de afinidad para albumina de suero humano. |
GB9902000D0 (en) | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CA2405563A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050100991A1 (en) * | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050244931A1 (en) * | 2001-04-12 | 2005-11-03 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20060084794A1 (en) * | 2001-04-12 | 2006-04-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050054051A1 (en) * | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
AU2002332041A1 (en) * | 2001-10-05 | 2003-04-22 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
ES2500918T3 (es) | 2001-12-21 | 2014-10-01 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina e interferón beta |
AU2002364587A1 (en) * | 2001-12-21 | 2003-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CN1646154B (zh) | 2002-02-07 | 2010-12-01 | 诺维信生物制药英国有限公司 | 与白蛋白融合的抗-血管生成肽 |
GB0217033D0 (en) | 2002-07-23 | 2002-08-28 | Delta Biotechnology Ltd | Gene and polypeptide sequences |
EP1594530A4 (en) | 2003-01-22 | 2006-10-11 | Human Genome Sciences Inc | HYBRID PROTEINS OF ALBUMIN |
JP5236189B2 (ja) | 2003-12-05 | 2013-07-17 | チルドレンズ ホスピタル メディカル センター | オリゴ糖組成物および感染症の治療における該組成物の使用 |
GB0329722D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Modified plasmid and use thereof |
GB0329681D0 (en) | 2003-12-23 | 2004-01-28 | Delta Biotechnology Ltd | Gene expression technique |
US8420087B2 (en) | 2004-01-05 | 2013-04-16 | Antisoma Research Limited | Interleukin-12 targeted to oncofoetal fibronectin |
EP1831375B1 (en) | 2004-12-23 | 2014-07-16 | Novozymes Biopharma DK A/S | Gene expression technique |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
AU2007278994B2 (en) | 2006-07-24 | 2013-08-15 | Biorexis Pharmaceutical Corporation | Exendin fusion proteins |
EP2054437A2 (en) | 2006-08-07 | 2009-05-06 | Teva Biopharmaceuticals USA, Inc. | Albumin-insulin fusion proteins |
US20090252703A1 (en) * | 2006-10-19 | 2009-10-08 | Gegg Jr Colin V | Use of alcohol co-solvents to improve pegylation reaction yields |
PE20081140A1 (es) * | 2006-10-25 | 2008-09-22 | Amgen Inc | Agentes terapeuticos a base de peptidos derivados de toxinas |
AU2008262490B2 (en) * | 2007-05-22 | 2011-11-17 | Amgen Inc. | Compositions and methods for producing bioactive fusion proteins |
EP2594583A1 (en) | 2007-08-08 | 2013-05-22 | Novozymes Biopharma DK A/S | Transferrin variants and conugates |
US20110294988A1 (en) | 2009-02-06 | 2011-12-01 | Novozymes Bio Pharma DK A/S | Purification Process |
CN106986933A (zh) | 2009-02-11 | 2017-07-28 | 阿尔布梅迪克斯医疗公司 | 白蛋白变体和缀合物 |
MX347291B (es) | 2009-03-20 | 2017-04-17 | Amgen Inc | Inmunoglobulinas portadoras y usos de las mismas. |
CA2781532A1 (en) | 2009-11-20 | 2011-05-26 | Amgen Inc. | Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1 |
EP2603794A1 (en) | 2010-08-10 | 2013-06-19 | Amgen Inc. | Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies |
WO2012040518A2 (en) | 2010-09-22 | 2012-03-29 | Amgen Inc. | Carrier immunoglobulins and uses thereof |
SG191993A1 (en) | 2011-01-18 | 2013-08-30 | Amgen Inc | Nav1.7 knockout mice and uses thereof |
AU2012222833B2 (en) | 2011-03-03 | 2017-03-16 | Zymeworks Inc. | Multivalent heteromultimer scaffold design and constructs |
CN103930437A (zh) | 2011-03-16 | 2014-07-16 | 安姆根有限公司 | Nav1.3和Nav1.7的强效及选择性抑制剂 |
CA2864702A1 (en) | 2012-02-22 | 2013-08-29 | Amgen Inc. | Autologous mammalian models derived from induced pluripotent stem cells and related methods |
JP6498601B2 (ja) | 2012-07-13 | 2019-04-10 | ザイムワークス,インコーポレイテッド | 多価ヘテロ多量体足場設計および構築物 |
EP2970408B1 (en) | 2013-03-12 | 2018-01-10 | Amgen Inc. | Potent and selective inhibitors of nav1.7 |
AU2014262566A1 (en) | 2013-05-08 | 2015-11-12 | Zymeworks Inc. | Bispecific HER2 and HER3 antigen binding constructs |
EP3039129B1 (en) | 2013-08-30 | 2018-06-27 | Amgen Inc. | High titer recombinant aav vector production in adherent and suspension cells |
EP3206707B1 (en) | 2014-10-13 | 2020-12-02 | University of Maryland, Baltimore | Fc-ela-32 and its use in the treatment of cardiac conditions |
MX2017004769A (es) | 2014-10-15 | 2017-10-16 | Amgen Inc | Elementos promotores y reguladores para mejorar la expresion de genes heterologos en celulas hospederas. |
CA2874083C (en) | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
CA3005953A1 (en) | 2015-12-22 | 2017-06-29 | Albumedix Ltd | Improved protein expression strains |
ES2823173T3 (es) | 2016-01-27 | 2021-05-06 | Just Biotherapeutics Inc | Promotor híbrido y usos del mismo |
US11135266B2 (en) | 2016-11-21 | 2021-10-05 | Just-Evotec Biologics, Inc. | Aflibercept formulations and uses thereof |
ES2906997T3 (es) | 2017-06-20 | 2022-04-21 | Albumedix Ltd | Cepas de expresión de proteínas mejoradas |
WO2019036626A1 (en) | 2017-08-17 | 2019-02-21 | Just Biotherapeutics, Inc. | PROCESS FOR PURIFYING GLYCOSYLATED PROTEIN FROM GALECTINES AND OTHER HOST CELL CONTAMINANTS |
WO2019099965A1 (en) | 2017-11-20 | 2019-05-23 | Just Biotherapeutics, Inc. | Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof |
KR20210127947A (ko) | 2019-02-15 | 2021-10-25 | 저스트-에보텍 바이오로직스, 아이엔씨. | 자동화된 바이오 제조 시스템, 설비 및 공정 |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
WO2023287707A1 (en) | 2021-07-15 | 2023-01-19 | Just-Evotec Biologics, Inc. | Bidirectional tangential flow filtration (tff) perfusion system |
WO2023154305A2 (en) | 2022-02-10 | 2023-08-17 | Amgen Inc. | Antibody protein product expression constructs for high throughput sequencing |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ207926A (en) * | 1983-04-25 | 1988-04-29 | Genentech Inc | Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast |
NZ207925A (en) * | 1983-04-25 | 1988-05-30 | Genentech Inc | Yeast expression vehicle consisting of a yeast promoter and signal peptide encoding region linked to a heterologus peptide coding region; expression and culture |
US4588684A (en) * | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
AU5912586A (en) * | 1985-06-20 | 1986-12-24 | Salk Institute Biotechnology/Industrial Associates, Inc., The | Alpha-factor leader peptide-facilitated secretion from transformed s cerevisiae |
RU2091490C1 (ru) * | 1985-10-25 | 1997-09-27 | Зимодженетикс, Инк. | Способ получения гетерологичного полипептида в эукариотических микроорганизмов |
EP0243465A1 (en) * | 1985-10-25 | 1987-11-04 | Vivian L. Mackay | Method of using bar1 for secreting foreign proteins |
GB8613388D0 (en) * | 1986-06-03 | 1986-07-09 | Delta Biotechnology Ltd | Induction of galactose regulated gene expression in yeast |
IT1196484B (it) * | 1986-07-11 | 1988-11-16 | Sclavo Spa | Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe |
JP2507874B2 (ja) * | 1986-11-27 | 1996-06-19 | 工業技術院長 | 分泌シグナルペプチドをコ−ドするdna配列 |
-
1989
- 1989-07-14 EP EP89909015A patent/EP0387319B1/en not_active Expired - Lifetime
- 1989-07-14 DE DE68925893T patent/DE68925893T2/de not_active Expired - Lifetime
- 1989-07-14 WO PCT/GB1989/000816 patent/WO1990001063A1/en active IP Right Grant
- 1989-07-14 AU AU40427/89A patent/AU633020B2/en not_active Expired
- 1989-07-14 KR KR1019900700595A patent/KR100195632B1/ko not_active IP Right Cessation
- 1989-07-14 AT AT89909015T patent/ATE135045T1/de not_active IP Right Cessation
- 1989-07-14 HU HU894572A patent/HU213571B/hu unknown
- 1989-07-14 JP JP01508293A patent/JP3092811B2/ja not_active Expired - Lifetime
- 1989-07-17 CA CA000605832A patent/CA1340547C/en not_active Expired - Fee Related
- 1989-07-18 IL IL9102489A patent/IL91024A/en unknown
- 1989-07-20 IE IE236189A patent/IE62266B1/en not_active IP Right Cessation
- 1989-12-21 GB GB8928849A patent/GB2230268B/en not_active Expired
-
1990
- 1990-03-21 FI FI901428A patent/FI104564B/fi active IP Right Grant
- 1990-03-21 DK DK199000729A patent/DK175853B1/da not_active IP Right Cessation
-
1993
- 1993-05-21 US US08/067,243 patent/US5302697A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK72990A (da) | 1990-03-21 |
IL91024A0 (en) | 1990-02-09 |
HU894572D0 (en) | 1991-05-28 |
GB2230268B (en) | 1992-01-29 |
FI104564B (fi) | 2000-02-29 |
IE892361L (en) | 1990-01-23 |
HU213571B (en) | 1997-08-28 |
FI901428A0 (fi) | 1990-03-21 |
AU633020B2 (en) | 1993-01-21 |
JP3092811B2 (ja) | 2000-09-25 |
GB8928849D0 (en) | 1990-07-18 |
DE68925893D1 (de) | 1996-04-11 |
DE68925893T2 (de) | 1996-08-08 |
IE62266B1 (en) | 1995-01-11 |
HUT57829A (en) | 1991-12-30 |
DK72990D0 (da) | 1990-03-21 |
ATE135045T1 (de) | 1996-03-15 |
KR100195632B1 (ko) | 1999-06-15 |
GB2230268A (en) | 1990-10-17 |
KR920700288A (ko) | 1992-02-19 |
US5302697A (en) | 1994-04-12 |
WO1990001063A1 (en) | 1990-02-08 |
CA1340547C (en) | 1999-05-18 |
EP0387319A1 (en) | 1990-09-19 |
JPH03500370A (ja) | 1991-01-31 |
EP0387319B1 (en) | 1996-03-06 |
IL91024A (en) | 1995-08-31 |
AU4042789A (en) | 1990-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE135045T1 (de) | Sekretorische leader-sequenzen | |
FI883541A (fi) | Dna-strukturer innehaollande styrsekvensen av kluyveromyces- -faktorn. | |
EP0218191A3 (en) | Formation of laminated structures by selective dielectric heating of bonding film | |
NO180593C (no) | Fremgangsmåte for fremstilling, i Saccharomyces cerevisiae, av et heterologt protein i homogen form | |
EP0799317B8 (en) | Method for secreting thrombopoietin polypeptides | |
EP0228254A3 (en) | Yeast secretion vectors | |
DK0746611T3 (da) | Fremgangsmåde til forøgelse af produktion af disulfid-bundne rekombinante proteiner af Saccharomyces Cerevisiae | |
HK1066816A1 (en) | Recombinant fusion proteins to growth hormone and serum albumin | |
DK0782625T3 (da) | Ekspression af og eksportteknologi for proteiner som immunfusiner | |
DE3276374D1 (en) | Plasmids coding for b. thuringiensis crystal protein, their production and their use in creating genetically engineered bacterial strains, the aforesaid strains per se and their use in producing said protein, said protein so-produced, insecticidal formulations comprising the same and a method of producing an insecticidal effect | |
EP0361991A3 (en) | Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast | |
CA2060666A1 (en) | Antigenic epitopes present on membrane-bound but not secreted iga | |
IT8621106A1 (it) | Vettore ad espressione e secrezione in lieviti, utile per la preparazione di proteine eterologhe | |
NO980293D0 (no) | Fremgangsmåte til fremstilling av et polypeptid | |
ES2067703T3 (es) | Cepa de saccharomyces cerevisiae productora de una proteina heterologa y procedimiento de preparacion de dicha proteina heterologa mediante fermentacion de dicha cepa. | |
ES8602137A1 (es) | Procedimiento para obtener una proteina heterologa para levaduras | |
DK0396436T3 (da) | Gærstammer til fremstilling af modne heterologe proteiner, især hirudin | |
ES2056785T3 (es) | Metodo de utilizacion de bar1 para la secrecion de proteinas extrañas. | |
ES2005756A6 (es) | Un metodo para liberar polipeptidos heterologos de proteinas de fusion. | |
WO1988000836A3 (fr) | Immunosuppresseur et son procede de fabrication | |
EP0385659A3 (en) | Multifunctional polypeptides and method for the preparation thereof | |
EP0352060A3 (en) | Expression plasmid and use thereof | |
Tekamp-Olson | Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences | |
FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |